menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Evolving the HER2-Positive Treatment Landscape: A Look at the Next Wave of Targeted Therapies for Breast Cancer

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    In the field of breast cancer, how far have targeted therapies come?  Dr. Maryam Lustberg, Assistant Professor of Internal Medicine in the Division of Medical Oncology at Ohio State University, shares some insight into the latest developments in the treatment of early-stage HER2-positive breast cancer.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    In the field of breast cancer, how far have targeted therapies come?  Dr. Maryam Lustberg, Assistant Professor of Internal Medicine in the Division of Medical Oncology at Ohio State University, shares some insight into the latest developments in the treatment of early-stage HER2-positive breast cancer.

Facebook Comments

Schedule27 Nov 2021
Webpack App